Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity

J Nephrol. 2016 Feb;29(1):37-44. doi: 10.1007/s40620-015-0199-8. Epub 2015 Apr 24.

Abstract

Background: The prevalence of obesity is increasing during the past decade along with obesity-related glomerulopathy (ORG), glomeruli injury due to the obesity. The major pathogenesis of ORG is the shedding of podocytes from the glomerular cell barrier into urine. Podocalyxin (PCX), a main surface antigen of podocyte, correlates well with glomerulosclerosis progression and glomerular injury severity, and might be a potential biomarker for early renal alteration in obesity. In addition, vascular endothelial growth factor (VEGF) and alpha-smooth muscle actin (α-SMA) also play a role in promoting glomerulosclerosis. The aim of this study was to explore whether obese subjects without other diseases excrete more PCX-positive (PCX+) cells than non-obese individuals, in comparison with urine protein-creatinine ratio (UPCR) and glomerular filtration rate (GFR) as traditional renal markers. Moreover, the effect of body mass index (BMI) on urinary VEGF, PCX or α-SMA positive cells was also investigated.

Methods: Forty-eight obese and 13 non-obese adults were included. Exfoliated cells from fresh first void morning urine were harvested, stained with PCX, VEGF, and α-SMA antibody, and quantified by flow cytometry. Correlation between interested urinary biomarkers (cells positive for PCX, VEGF plus PCX and α-SMA), UPCR and GFR with BMI and metabolic risk factors were analyzed.

Results: Obese patients had significantly higher PCX+ cells than non-obese [0.62 (0.00-13.13) vs. 0.15 (0.00-0.72) cells/ml × mg cr, p < 0.05]. There was no significant difference in GFR and UPCR between the groups. Of interest, BMI demonstrated a correlation with PCX+ cells (r = 0.343, p = 0.008) and cells positive for PCX plus VEGF (r = 0.374, p = 0.004).

Conclusion: Obese subjects without other diseases and with normal UPCR and GFR showed evidence of renal alteration through the detection of a higher number of PCX+ cells. Increasing BMI also resulted in higher number of PCX+ cells.

Keywords: Metabolic syndrome; Obesity; Podocalyxin; Podocyte; Proteinuria.

MeSH terms

  • Biomarkers / urine
  • Body Mass Index
  • Case-Control Studies
  • Creatinine / urine
  • Early Diagnosis
  • Glomerular Filtration Rate
  • Humans
  • Kidney Diseases / diagnosis*
  • Kidney Diseases / etiology
  • Kidney Diseases / physiopathology
  • Kidney Diseases / urine*
  • Obesity / complications*
  • Obesity / diagnosis
  • Podocytes / metabolism*
  • Predictive Value of Tests
  • Proteinuria / diagnosis
  • Proteinuria / etiology
  • Proteinuria / urine
  • Sialoglycoproteins / urine*
  • Urinalysis
  • Urine / cytology

Substances

  • Biomarkers
  • Sialoglycoproteins
  • podocalyxin
  • Creatinine